(LYSX) Multi Units France - Lyxor - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: FR0007054358 • Eurozone Large-Cap Equity
LYSX: Eurozone Stocks, Blue-chip Companies, Currency Hedge
The Lyxor EURO STOXX 50 (DR) UCITS ETF is a UCITS-compliant exchange-traded fund designed to replicate the performance of the EURO STOXX 50 Net Return EUR index. This index is a widely recognized benchmark for blue-chip companies in the Eurozone, comprising 50 leading stocks across 12 Eurozone countries. The fund incorporates a USD hedging mechanism to mitigate currency risk, making it suitable for investors seeking Eurozone exposure without direct currency fluctuations. The ETF holds a significant position in sectors such as financials, industrials, and consumer goods, aligning with the broader Eurozone economy.
The funds underlying index, EURO STOXX 50, captures approximately 60% of the free-float market capitalization of the EURO STOXX Total Market Index (TMI), which itself covers about 95% of the free-float market capitalization of the represented countries. This ensures broad diversification and representation of the Eurozones largest and most liquid companies. The fund is listed on XETRA under the ticker LYSX and is categorized as a Eurozone Large-Cap Equity ETF.
Based on the provided
Over the next three months, the Lyxor EURO STOXX 50 (DR) UCITS ETF is expected to maintain its upward trajectory, supported by strong fundamentals and positive technical indicators. The 20-day SMA crossing above the 200-day SMA indicates a bullish trend, while the ATR of 1.17 suggests manageable volatility. The funds AUM of 2,429.17M EUR reflects its stability and investor confidence. Anticipate a price target range of 58.50 to 62.00 EUR, driven by the broader Eurozone economic recovery and corporate earnings growth.
Additional Sources for LYSX ETF
LYSX ETF Overview
Market Cap in USD | 2,750m |
Category | Eurozone Large-Cap Equity |
TER | 0.20% |
IPO / Inception | 2001-02-19 |
LYSX ETF Ratings
Growth Rating | 73.5 |
Fundamental | - |
Dividend Rating | 1.0 |
Rel. Strength | -2.16 |
Analysts | - |
Fair Price Momentum | 56.12 EUR |
Fair Price DCF | - |
LYSX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 70.2% |
LYSX Growth Ratios
Growth Correlation 3m | -56.2% |
Growth Correlation 12m | 43.4% |
Growth Correlation 5y | 90.9% |
CAGR 5y | 15.39% |
CAGR/Max DD 5y | 0.66 |
Sharpe Ratio 12m | 1.13 |
Alpha | -3.11 |
Beta | 0.601 |
Volatility | 18.28% |
Current Volume | 35.8k |
Average Volume 20d | 35.3k |
As of May 02, 2025, the stock is trading at EUR 56.32 with a total of 35,823 shares traded.
Over the past week, the price has changed by +0.79%, over one month by -2.68%, over three months by -0.55% and over the past year by +8.06%.
Yes. Based on ValueRay Analyses, Multi Units France - Lyxor (XETRA:LYSX) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.46 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYSX as of May 2025 is 56.12. This means that LYSX is currently overvalued and has a potential downside of -0.36%.
Multi Units France - Lyxor has no consensus analysts rating.
According to ValueRays Forecast Model, LYSX Multi Units France - Lyxor will be worth about 63.1 in May 2026. The stock is currently trading at 56.32. This means that the stock has a potential upside of +12.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 63.1 | 12% |